Iichirou Shimomura


Ontology type: schema:Person     


Person Info

NAME

Iichirou

SURNAME

Shimomura

Publications in SciGraph latest 50 shown

  • 2022-06-16 Ketone body 3-hydroxybutyrate enhances adipocyte function in SCIENTIFIC REPORTS
  • 2022-06-04 Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus in BMC ENDOCRINE DISORDERS
  • 2022-05-05 Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade in DIABETOLOGIA
  • 2022-04-26 Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER in BMC ENDOCRINE DISORDERS
  • 2022-03-10 Motivation for Treatment Correlating Most Strongly with an Increase in Satisfaction with Type 2 Diabetes Treatment in DIABETES THERAPY
  • 2022-03-09 Adiponectin accumulation in the retinal vascular endothelium and its possible role in preventing early diabetic microvascular damage in SCIENTIFIC REPORTS
  • 2022-03-03 Spatial and transcriptional heterogeneity of pancreatic beta cell neogenesis revealed by a time-resolved reporter system in DIABETOLOGIA
  • 2022-02-05 Evaluation of the effect of tofogliflozin on the tissue characteristics of the carotid wall—a sub-analysis of the UTOPIA trial in CARDIOVASCULAR DIABETOLOGY
  • 2022-01-19 Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease in HYPERTENSION RESEARCH
  • 2021-12-28 Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER in DIABETES THERAPY
  • 2021-12-07 Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity in DIABETOLOGY INTERNATIONAL
  • 2021-11-26 Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity in DIABETOLOGY INTERNATIONAL
  • 2021-11-08 Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity in DIABETOLOGY INTERNATIONAL
  • 2021-10-23 Correction to: Glycemic control of people with diabetes over months after the 2018 North Osaka Earthquake in DIABETOLOGY INTERNATIONAL
  • 2021-10-17 Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study in HYPERTENSION RESEARCH
  • 2021-10-02 Acute effects of whole body vibration exercise on post-load glucose metabolism in healthy men: a pilot randomized crossover trial in ENDOCRINE
  • 2021-09-07 Increased NKX6.1 expression and decreased ARX expression in alpha cells accompany reduced beta-cell volume in human subjects in SCIENTIFIC REPORTS
  • 2021-08-06 The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus in DIABETES THERAPY
  • 2021-05-04 Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes in CARDIOVASCULAR DIABETOLOGY
  • 2021-01-28 Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2) in ADVANCES IN THERAPY
  • 2021-01-07 Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes in CARDIOVASCULAR DIABETOLOGY
  • 2021-01-04 Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial in CARDIOVASCULAR DIABETOLOGY
  • 2021-01-02 Psychosocial conditions and the progression of diabetic nephropathy in Japanese with type 2 diabetes mellitus in DIABETOLOGY INTERNATIONAL
  • 2021-01-01 Association of abdominal obesity with crossing capillaries in the finger nailfold in type 2 diabetes mellitus in DIABETOLOGY INTERNATIONAL
  • 2020-11-23 Renal function is associated with blood neurofilament light chain level in older adults in SCIENTIFIC REPORTS
  • 2020-08-18 Age-dependent loss of adipose Rubicon promotes metabolic disorders via excess autophagy in NATURE COMMUNICATIONS
  • 2020-07-17 Author Correction: Adiponectin promotes muscle regeneration through binding to T-cadherin in SCIENTIFIC REPORTS
  • 2020-07-09 Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study in CARDIOVASCULAR DIABETOLOGY
  • 2020-06-11 Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes in CARDIOVASCULAR DIABETOLOGY
  • 2020-06-05 Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study in DIABETES THERAPY
  • 2020-05-26 Glycemic control of people with diabetes over months after the 2018 North Osaka Earthquake in DIABETOLOGY INTERNATIONAL
  • 2020-04-11 Effect of tasteless calorie-free gum chewing before meal on postprandial plasma glucose, insulin, glucagon, and gastrointestinal hormones in Japanese men without diagnosed glucose metabolism disorder: a pilot randomized crossover trial in DIABETOLOGY INTERNATIONAL
  • 2020-03-09 Plasma lipopolysaccharide binding protein level statistically mediates between body mass index and chronic microinflammation in Japanese patients with type 1 diabetes in DIABETOLOGY INTERNATIONAL
  • 2019-07-23 Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes in DIABETES THERAPY
  • 2019-03-22 Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype in CARDIOVASCULAR DIABETOLOGY
  • 2019-03-08 The number of positive confirmatory tests is associated with the clinical presentation and incidence of cardiovascular and cerebrovascular events in primary aldosteronism in HYPERTENSION RESEARCH
  • 2019-01-09 Adiponectin promotes muscle regeneration through binding to T-cadherin in SCIENTIFIC REPORTS
  • 2018-11-28 Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program) in CARDIOVASCULAR DIABETOLOGY
  • 2018-10-23 Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L in ACTA DIABETOLOGICA
  • 2018-08-04 Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation in CARDIOVASCULAR DIABETOLOGY
  • 2018-06-11 Metabolomic and microarray analyses of adipose tissue of dapagliflozin-treated mice, and effects of 3-hydroxybutyrate on induction of adiponectin in adipocytes in SCIENTIFIC REPORTS
  • 2018-04-12 Diffusion-weighted magnetic resonance imaging in the pancreas of fulminant type 1 diabetes in DIABETOLOGY INTERNATIONAL
  • 2018-02-05 Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE) in CARDIOVASCULAR DIABETOLOGY
  • 2018-01-12 Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial in DIABETES THERAPY
  • 2017-12-19 Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan—A Protocol in DIABETES THERAPY
  • 2017-09-20 Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis in DIABETES THERAPY
  • 2017-09-01 Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study in DIABETES THERAPY
  • 2017-07-06 Westernization of lifestyle affects quantitative and qualitative changes in adiponectin in CARDIOVASCULAR DIABETOLOGY
  • 2017-07-04 Eicosapentaenoic acid and 5-HEPE enhance macrophage-mediated Treg induction in mice in SCIENTIFIC REPORTS
  • 2017-05-17 The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis in DIABETES THERAPY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.136593.b", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419841.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.255464.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.31432.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.189504.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419082.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410818.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.267313.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416214.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410834.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414317.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412334.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417245.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.265073.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410844.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412398.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416709.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239395.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.462844.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.267335.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.258799.8", 
            "type": "Organization"
          }
        ], 
        "familyName": "Shimomura", 
        "givenName": "Iichirou", 
        "id": "sg:person.01364115125.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364115125.40"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-12-01T07:12", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/person/person_618.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01364115125.40'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01364115125.40'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01364115125.40'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01364115125.40'


     

    This table displays all metadata directly associated to this object as RDF triples.

    58 TRIPLES      10 PREDICATES      32 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01364115125.40 schema:affiliation N61f14b550f4246aab40aed0f2d93c949
    2 grid-institutes:grid.189504.1
    3 grid-institutes:grid.239395.7
    4 grid-institutes:grid.255464.4
    5 grid-institutes:grid.258799.8
    6 grid-institutes:grid.265073.5
    7 grid-institutes:grid.267313.2
    8 grid-institutes:grid.267335.6
    9 grid-institutes:grid.31432.37
    10 grid-institutes:grid.38142.3c
    11 grid-institutes:grid.410818.4
    12 grid-institutes:grid.410834.a
    13 grid-institutes:grid.410844.d
    14 grid-institutes:grid.412334.3
    15 grid-institutes:grid.412398.5
    16 grid-institutes:grid.414317.4
    17 grid-institutes:grid.416214.4
    18 grid-institutes:grid.416709.d
    19 grid-institutes:grid.417245.1
    20 grid-institutes:grid.419082.6
    21 grid-institutes:grid.419841.1
    22 grid-institutes:grid.462844.8
    23 schema:familyName Shimomura
    24 schema:givenName Iichirou
    25 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364115125.40
    26 schema:sdDatePublished 2022-12-01T07:12
    27 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    28 schema:sdPublisher N4f49bfb6b37e4eaf8281737c4a68c94f
    29 sgo:license sg:explorer/license/
    30 sgo:sdDataset persons
    31 rdf:type schema:Person
    32 N4f49bfb6b37e4eaf8281737c4a68c94f schema:name Springer Nature - SN SciGraph project
    33 rdf:type schema:Organization
    34 N61f14b550f4246aab40aed0f2d93c949 schema:affiliation grid-institutes:grid.136593.b
    35 sgo:isCurrent true
    36 rdf:type schema:OrganizationRole
    37 grid-institutes:grid.136593.b schema:Organization
    38 grid-institutes:grid.189504.1 schema:Organization
    39 grid-institutes:grid.239395.7 schema:Organization
    40 grid-institutes:grid.255464.4 schema:Organization
    41 grid-institutes:grid.258799.8 schema:Organization
    42 grid-institutes:grid.265073.5 schema:Organization
    43 grid-institutes:grid.267313.2 schema:Organization
    44 grid-institutes:grid.267335.6 schema:Organization
    45 grid-institutes:grid.31432.37 schema:Organization
    46 grid-institutes:grid.38142.3c schema:Organization
    47 grid-institutes:grid.410818.4 schema:Organization
    48 grid-institutes:grid.410834.a schema:Organization
    49 grid-institutes:grid.410844.d schema:Organization
    50 grid-institutes:grid.412334.3 schema:Organization
    51 grid-institutes:grid.412398.5 schema:Organization
    52 grid-institutes:grid.414317.4 schema:Organization
    53 grid-institutes:grid.416214.4 schema:Organization
    54 grid-institutes:grid.416709.d schema:Organization
    55 grid-institutes:grid.417245.1 schema:Organization
    56 grid-institutes:grid.419082.6 schema:Organization
    57 grid-institutes:grid.419841.1 schema:Organization
    58 grid-institutes:grid.462844.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...